Pathway Therapeutics

Biotechnology, Medical Device, Therapeutics
Founded in 2008-01-01
San Francisco, California, United States
http://pathwaytx.com
For Profit

About Pathway Therapeutics

Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 9 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 24400000 USD
  • Last Funding: 400000 USD (Debt Financing)
  • Funding Status: Early Stage Venture

Technology Stack

Pathway Therapeutics actively uses 9 products in their tech stack.

Market Presence

Industries: Biotechnology, Medical Device, Therapeutics

Headquarters: San Francisco, California, United States